Statement of Organization, Functions, and Delegations of Authority, 44687-44688 [2024-11058]
Download as PDF
<![CDATA[
44687
Federal Register / Vol. 89, No. 99 / Tuesday, May 21, 2024 / Notices
specific aspects of the information
collection described above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
OPREinfocollection@acf.hhs.gov.
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: OPRE is conducting the
BIAS–NG project, which uses
behavioral insights to design and test
interventions intended to improve the
efficiency, operations, and efficacy of
human services programs. The BIAS–
NG project is applying and testing
behavioral insights to ACF programs
including TANF, child welfare, and
EHS/HS, and intends to expand these
efforts to child care. This notice is a
request for comments on ACF’s proposal
to revise and extend a previously
approved collection, which included
data collection to design and test
interventions in the TANF, child
welfare, and EHS/HS domains. Under
the approved pilot generic clearance,
OPRE has already conducted work with
seven sites to conduct seven tests, and
is planning to continue to work with at
least one additional site, conducting one
or more tests of behavioral interventions
for a total of nine tests of behavioral
interventions. All approved information
collection activities can be found here:
https://www.reginfo.gov/public/do/
PRAICList?ref_nbr=202206-0970-002.
In addition to extending approval,
this approval would also allow OPRE to
conduct tests in the newly added
program area of child care. The design
and testing of BIAS–NG interventions is
rapid and, to the extent possible,
iterative. Each specific intervention is
designed in consultation with agency
leaders and launched as quickly as
possible. To maximize the likelihood
that the intervention produces
measurable, significant, and positive
effects on outcomes of interest, rapid
cycle evaluation techniques will be
employed in which proximate outcomes
will be measured to allow the research
team to more quickly iterate and adjust
the intervention design, informing
subsequent tests. Due to the rapid and
iterative nature of this work, OPRE
sought and received approval for an
overarching generic clearance to
conduct this research. Following
standard OMB requirements for generic
clearances, once instruments subject to
PRA are tailored to a specific site and
the site’s intervention, OPRE submits an
individual generic information
collection request under this umbrella
clearance. Each request includes the
individual instrument(s), a justification
specific to the individual information
collection, a description of the proposed
intervention, and any supplementary
documents. Each specific information
collection includes up to two
submissions—one submission for the
formative stage research and another
submission for any further data
collection requiring burden during the
testing phase. The type of information to
be collected and the uses of the
information is described in the
supporting statements, found here:
https://www.reginfo.gov/public/do/
PRAViewDocument?ref_nbr=2022060970-002.
Respondents: (1) Program
Administrators, (2) Program Staff, and
(3) Program Clients.
ANNUAL BURDEN ESTIMATES (TANF, CHILD WELFARE, EHS/HS, CHILD CARE)
Number of
respondents
(TANF, CW,
EHS/HS, CC)
(total over
request
period)
Instrument
Number of
responses per
respondent
(total over
request
period)
Average
burden hours
per response
(in hours)
Total burden
(in hours)
Annual
burden
(in hours)
Phase 3: Diagnosis and Design
Administrator interviews/focus groups .................................
Staff interviews/focus groups ...............................................
Client interviews/focus groups .............................................
Client survey ........................................................................
Staff Survey .........................................................................
48
400
400
400
400
1
1
1
1
1
1
1
1
.25
.25
48
400
400
100
100
16
133
133
33
33
1
1
1
1
1
1
1
1
.25
.25
96
800
800
3,000
300
32
267
267
1,000
100
Phase 4: Evaluation
ddrumheller on DSK120RN23PROD with NOTICES1
Administrator interviews/focus groups .................................
Staff interviews/focus groups ...............................................
Client interviews/focus groups .............................................
Client survey ........................................................................
Staff Survey .........................................................................
Estimated Total Annual Burden
Hours: 2,014.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
VerDate Sep<11>2014
18:13 May 20, 2024
Jkt 262001
96
800
800
12,000
1,200
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1310.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Statement of Organization, Functions,
and Delegations of Authority
Mary C. Jones,
ACF/OPRE Certifying Officer.
Office of Population Affairs,
Office of the Assistant Secretary for
Health, Office of the Secretary,
Department of Health and Human
Services (HHS).
[FR Doc. 2024–11077 Filed 5–20–24; 8:45 am]
ACTION:
AGENCY:
Notice.
BILLING CODE 4184–07–P
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\21MYN1.SGM
21MYN1
44688
Federal Register / Vol. 89, No. 99 / Tuesday, May 21, 2024 / Notices
The Office of the Assistant
Secretary for Health, Office of
Population Affairs (OPA) has modified
its organizational structure.
DATES: This new organizational
structure was approved by the Secretary
of Health and Human Services and takes
effect on May 14, 2024.
FOR FURTHER INFORMATION CONTACT:
Jessica Swafford Marcella, Deputy
Assistant Secretary for Population
Affairs, Office of Population Affairs,
Office of the Assistant Secretary for
Health, Department of Health and
Human Services at Jessica.marcella@
hhs.gov and 240–453–2800.
SUPPLEMENTARY INFORMATION: Part A
(Office of the Secretary, U.S.
Department of Health and Human
Services) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (60 FR 56605, dated November
9, 1995, and corrected at 75 FR 53304,
August 31, 2010, amended at 82 FR
3005, dated January 10, 2017, and
amended, most recently at 84 FR 14951,
dated April 12, 2019) is amended to
reflect the reorganization of the Office of
Population Affairs (OPA), Office of the
Assistant Secretary for Health (OASH).
This reorganization will streamline
operations and improve the efficiency
and effectiveness of OPA. OPA is
responsible for implementing and
administering the Title X family
planning program, managing the Office
of Adolescent Health, which is headed
by a director, and implementing and
administering the Teen Pregnancy
Prevention program and other
adolescent health activities. The
changes are as follows:
I. Under Part C, section C–G,
Organization, revise to organize OPA
staff across six Divisions:
Administration and Operations,
Adolescent Health Programs, Clinical
and Scientific Affairs, Policy and
External Affairs, Research and
Evaluation, and Title X Service
Delivery. The Division of
Administration and Operations will
manage overall operations for OPA,
including staff recruitment and
retention, budgeting, training, and
travel. The Division of Adolescent
Health Programs will lead
implementation of the Teen Pregnancy
Prevention Program and other
adolescent health programmatic
activities. The Division of Clinical and
Scientific Affairs will provide clinical
and scientific expertise, consultation,
and oversight for all OPA staff and
activities. The Division of Policy and
External Affairs will lead all policy and
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:13 May 20, 2024
Jkt 262001
communication activities for the office.
The Division of Research and
Evaluation will oversee data collection
for OPA programs and will lead OPA’s
research and evaluation activities. The
Division of Title X Service Delivery will
lead implementation of the Title X
service delivery program.
II. Delegations of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegations, if allowed, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Xavier Becerra,
Secretary, U.S. Department of Health and
Human Services.
[FR Doc. 2024–11058 Filed 5–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–4 Study
Section.
Date: June 14, 2024.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Steven G Britt, MD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–480–
1953, steve.britt@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Emphasis Panel; Review of UE5 Training
Applications.
Date: July 12, 2024.
Time: 2:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11067 Filed 5–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; HEAL
Initiative: Translating Research To Practice to
End the Overdose Crisis.
Date: June 27, 2024.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sheila Pirooznia, Ph.D.,
Scientific Review Officer, Division of
Extramural Review, Scientific Review
Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC,
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 89, Number 99 (Tuesday, May 21, 2024)]
[Notices]
[Pages 44687-44688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11058]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Office of Population Affairs, Office of the Assistant Secretary
for Health, Office of the Secretary, Department of Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 44688]]
SUMMARY: The Office of the Assistant Secretary for Health, Office of
Population Affairs (OPA) has modified its organizational structure.
DATES: This new organizational structure was approved by the Secretary
of Health and Human Services and takes effect on May 14, 2024.
FOR FURTHER INFORMATION CONTACT: Jessica Swafford Marcella, Deputy
Assistant Secretary for Population Affairs, Office of Population
Affairs, Office of the Assistant Secretary for Health, Department of
Health and Human Services at [email protected] and 240-453-2800.
SUPPLEMENTARY INFORMATION: Part A (Office of the Secretary, U.S.
Department of Health and Human Services) of the Statement of
Organization, Functions, and Delegations of Authority of the Department
of Health and Human Services (60 FR 56605, dated November 9, 1995, and
corrected at 75 FR 53304, August 31, 2010, amended at 82 FR 3005, dated
January 10, 2017, and amended, most recently at 84 FR 14951, dated
April 12, 2019) is amended to reflect the reorganization of the Office
of Population Affairs (OPA), Office of the Assistant Secretary for
Health (OASH). This reorganization will streamline operations and
improve the efficiency and effectiveness of OPA. OPA is responsible for
implementing and administering the Title X family planning program,
managing the Office of Adolescent Health, which is headed by a
director, and implementing and administering the Teen Pregnancy
Prevention program and other adolescent health activities. The changes
are as follows:
I. Under Part C, section C-G, Organization, revise to organize OPA
staff across six Divisions: Administration and Operations, Adolescent
Health Programs, Clinical and Scientific Affairs, Policy and External
Affairs, Research and Evaluation, and Title X Service Delivery. The
Division of Administration and Operations will manage overall
operations for OPA, including staff recruitment and retention,
budgeting, training, and travel. The Division of Adolescent Health
Programs will lead implementation of the Teen Pregnancy Prevention
Program and other adolescent health programmatic activities. The
Division of Clinical and Scientific Affairs will provide clinical and
scientific expertise, consultation, and oversight for all OPA staff and
activities. The Division of Policy and External Affairs will lead all
policy and communication activities for the office. The Division of
Research and Evaluation will oversee data collection for OPA programs
and will lead OPA's research and evaluation activities. The Division of
Title X Service Delivery will lead implementation of the Title X
service delivery program.
II. Delegations of Authority: All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegations, if allowed, provided they are consistent with this
reorganization.
(Authority: 44 U.S.C. 3101)
Xavier Becerra,
Secretary, U.S. Department of Health and Human Services.
[FR Doc. 2024-11058 Filed 5-20-24; 8:45 am]
BILLING CODE P
